enabling molecular detection anywhere

The FAST Chip

DIAGNOSTICS TO FIGHT EPIDEMICS AT THEIR SOURCE

RAPIDLY DEPLOYABLE AGAINST EMERGING OUTBREAKS

  • FIELD READY

    Zero power required. Autonomous unit. Simple smartphone analysis.

    Affordable

    Injection molding allows mass production of chips at cost 1000 times lower than PCR

  • Sensitive

    Isothermal nucleic acid amplification allows sensitivity comparable to PCR. Quantitative analysis determines concentration of pathogens.

  • Trackable

    Quick and accurate results allow real-time tracking of outbreak, conveying important information during most crucial times of outbreak.


Founding Team

Uploaded image

Charlie Yeh

Co-founder & CEO
Charlie invented the FAST chip while earning his PhD in Bioengineering in the joint UCSF/UC Berkeley program. Specializing in microfluidics, he saw the huge potential and need for inexpensive, rapidly deployable diagnostics.
Uploaded image

Danica Helb

Co-founder & CSO
Danica received her PhD specializing in infectious diseases from UC Berkeley. She previously developed the Cepheid MTB/RIF tuberculosis assay – one of the world’s most successful point-of-care assays to date.

RECENT NEWS

UC Berkeley invests in mFluiDx

Novemer 2016: mFluiDx completes equity deal with UC Berkeley, making UC Berkeley one of its largest external stakeholders




mFluiDx is accepted into the CITRIS Foundry program

November 2016: mFluiDx is one of 7 startups chosen from an applicant pool of 87 teams to participate in the UC Berkeley-led CITRIS Foundry program.



TechCrunch Disrupt

September 2016: mFluiDx is one of the top 20 companies selected from a global pool of 900 startups to present at TechCrunch Disrupt

  • mFluiDx competing on the startup battlegrounds at TechCrunch Disrupt!


IndieBio Demo Day

July 2016: mFluiDx graduates from the IndieBio accelerator program and presents to investors on demo day

  • CEO Charlie Yeh presenting to over 400 investors.


mFluiDx joins QB3 network

March 2016: mFluiDx plugs into the resources of QB3.





AS FEATURED IN

       


       


   


An Indiebio Accelerator Startup

Please contact us below